Bone Tumor Ablation Devices Market Segmentation Application, Technology and Market Analysis to 2027

The “Bone Tumor Ablation Devices Market” Research Report 2021-2027 is a specialized and in-depth study of the Bone Tumor Ablation Devices industry with a focus on the global market trend. The report aims to provide an overview of global Bone Tumor Ablation Devices Market with detailed market segmentation by component, deployment model, end-user and geography. The global Bone Tumor Ablation Devices Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Bone Tumor Ablation Devices Market players and offers key trends and opportunities in the market.

Request Here For PDF Brochure

Impact of Coronavirus (Covid-19) Pandemic

In majority of bone tumor patients, bone tumor ablation surgery is required for curing and managing the painful bone metastatic. The treatment techniques such as chemo-therapy, immune-therapy, and surgery of cancer patients were often postponed or cancelled due to COVID-19 pandemic. During this period, the bone tumor ablation surgery has become a preferable option for treatment due to its minimal invasiveness, time, and its cost-effectiveness. In 2014, the NCBI revealed that the bone tumor ablation of painful metastatic bone disorder is considered as safe and is observed to minimize the pain and has shown improved life quality for cancer patients. During the pandemic, the provision of care services to the bone cancer patients was challenging considering the risk of death of cancer patients against the death of patients from SARS-CoV-2 along with the higher chances of COVID-19 in immune comprised hosts.

The bone tumor ablation devices market is expected to deliver a CAGR of 10.2% over the forecast period (2020-2027) and is estimated to be worth at US$ 56.2 million in 2020.

Overview

When the cells within a bone are divided without control, bone tumor is developed which forms a lump or mass of abnormal tissue. This bone tumors are mostly benign i.e., not cancerous and generally not life-threatening and do not spread in other parts of the body in most cases. On basis of the tumor type, there are wide range of treatments from clinical observation to surgery for the tumor removal. The health of bone significantly worsens with age which leads to more number of accidents and consequent fractures. In 2014, the National Osteoporosis Foundation had released statistics which revealed that around 43.4 million adults had low bone mass and another 10 million adults had osteoporosis, signifying over 1/4^th adult population in U.S. was affected by bone disorders in 2013.

For treatment of bone tumors, there are various ablation techniques available which provide several benefits such as these techniques being least invasive, enable tumor destruction targets, and low complication rates. The most commonly used techniques are Radio-frequency Thermal Ablation (RFTA) and Cryosurgery.

Drivers

Rising launches of bone tumor ablation devices products is expected to stimulate growth of the global bone tumor ablation devices market.

Involvement of major players of the market in development and launch of novel bone tumor ablation devices is expected to significantly drive growth of the global bone tumor ablation devices market and generate a conductive environment for this market during the forecast period. In January 2016, Medtronic Plc., launched OsteoCool RF ablation system for treatment of spine metastases which provides dual-probe and simultaneous capabilities in treatment of painful bone tumors. In 2017, Medtronic Plc., launched OsteoCool RF ablation system for indication bone metastases in Canada. Moreover, in 2015, DFINE Inc., launched a Long SpineStar ablation instrument for metastatic spine tumor’s palliative treatment. This SpineStar ablation instrument is the only steerable and navigational radio-frequency device available in the market.

Moreover, rising cases of bone cancer are expected to create promising opportunities for growth of the bone tumor ablation devices market. In 2016, the American Cancer Society (ACS) had reported about 3,300 new cases of bone cancer along with 1,490 deaths in the U.S. Furthermore, the source continued that around 40% of primary bone cancers were chondrosarcomas in adults.

Market Segmentation

• On the basis of Indication: Ewing’s Sarcoma, Osteosarcoma, Metastatic Bone Cancer, Chondrosarcoma, and Others.

• On the basis of Technology: Cryoablation, Radiofrequency Ablation, Microwave Ablation, and Others.

• On the basis of End User: Specialty Clinics, Hospitals, and Ambulatory Surgical Centers.

Restraints

Major factors such as lack of awareness regarding the novel technologies and therapy advancements among the patients and healthcare professionals about the bone tumor ablation surgery, is expected to hamper growth of the bone tumor ablation devices market. The awareness of such novel technologies is very low among the rural areas of emerging economies such as Asia Pacific and Africa, which is expected to a major restraining factor in adoption of bone tumor ablation devices in these regions, hence limiting the market growth. Furthermore, scarcity of skilled professionals for surgery in these regions, minimal lifespan of bone tumor ablation devices, and the higher time for approval for the launch of product are all expected to be the major hindering factors in growth of the bone tumor ablation market over the forecast period.

Regional Analysis

Over the forecast period, the North American region is expected to be the most lucrative region for the bone tumor ablation devices market. Increase in prevalence of osteosarcoma is expected to propel the market growth in this region. As per the report from American Cancer Society, every year around 800-900 new cases of osteosarcoma are diagnosed in the U.S. with 50% of these cases occurring in teenagers and children, which is further expected to exhibit growth of the bone tumor ablation devices market in North American region.

Asia Pacific is expected to witness growth of the bone tumor ablation devices market due to the accelerated adoption of minimally invasive treatment therapies. The current conferences taking place in Asia Pacific region about the use of ablation technology are expected to create awareness about ablation technology among healthcare providers. In 2019, the Asian Conference of Tumor Ablation (ACTA) was held in Chang Gung Memorial Hospital of Taiwan on ablation technology. This conference mainly focused on technical tips and principles related to microwave ablation (MW), radio-frequency ablation (RFA), irreversible electroporation (IRE), cryoablation, and several guiding techniques with inclusion of imaging fusion were also introduced in this event.

Major Key Players Include In Bone Tumor Ablation Devices Market: Medtronic Plc., Merit Medical Systems Inc., MedWaves Inc., AngioDynamics Inc., Olympus Corporation, Varian Medical Systems, Inc., Mermaid Medical A/S, RF Medical Co., Ltd., and Misomix Inc.

Buy instant copy of this research report with Flat US $ 2000 Off@ – https://www.coherentmarketinsights.com/promo/buynow/4319

Main points in Bone Tumor Ablation Devices Market Report Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Bone Tumor Ablation Devices Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Bone Tumor Ablation Devices Industry Impact

Chapter 2 Global Bone Tumor Ablation Devices Competition by Types, Applications, and Top Regions and Countries
2.1 Global Bone Tumor Ablation Devices (Volume and Value) by Type
2.3 Global Bone Tumor Ablation Devices (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Bone Tumor Ablation Devices Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Bone Tumor Ablation Devices Market Analysis
Chapter 6 East Asia Bone Tumor Ablation Devices Market Analysis
Chapter 7 Europe Bone Tumor Ablation Devices Market Analysis
Chapter 8 South Asia Bone Tumor Ablation Devices Market Analysis
Chapter 9 Southeast Asia Bone Tumor Ablation Devices Market Analysis
Chapter 10 Middle East Bone Tumor Ablation Devices Market Analysis
Chapter 11 Africa Bone Tumor Ablation Devices Market Analysis
Chapter 12 Oceania Bone Tumor Ablation Devices Market Analysis
Chapter 13 South America Bone Tumor Ablation Devices Market Analysis
Chapter 14 Company Profiles and Key Figures in Bone Tumor Ablation Devices Business
Chapter 15 Global Bone Tumor Ablation Devices Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology

Request for a Sample Report

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com